Roivant to Stop Lung Disease Drug Development After Trial Failure ...Middle East

Medscape - News
Roivant will discontinue the development of its drug for a rare lung disease after it failed to show treatment benefits in patients in a mid-stage trial. Reuters Health Information

Hence then, the article about roivant to stop lung disease drug development after trial failure was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Roivant to Stop Lung Disease Drug Development After Trial Failure )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News